MTCH2 — Mitochondrial Carrier Homolog 2

MTCH2 — Mitochondrial Carrier Homolog 2

Introduction

MTCH2 (Mitochondrial Carrier Homolog 2), also known as mitochondrial carrier 2 or SYNDI, is a member of the mitochondrial carrier family (SLC25A family) that functions as an outer mitochondrial membrane protein involved in metabolite transport, apoptosis regulation, and mitochondrial dynamics [@zhang2019]. MTCH2 plays critical roles in neuronal survival and has been implicated in neurodegenerative diseases including Alzheimer's Disease and Parkinson's Disease.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Mitochondrial Carrier Homolog 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>MTCH2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitochondrial Carrier Homolog 2</td></tr>
<tr><td><strong>Chromosome</strong></td><td>11p15.4</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[123591](https://www.ncbi.nlm.nih.gov/gene/123591)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614215</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000135249</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y6C9](https://www.uniprot.org/uniprot/Q9Y6C9)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Metabolic Disorders, Cancer</td></tr>
</table>
</div>

Overview

MTCH2 — Mitochondrial Carrier Homolog 2

Introduction

MTCH2 (Mitochondrial Carrier Homolog 2), also known as mitochondrial carrier 2 or SYNDI, is a member of the mitochondrial carrier family (SLC25A family) that functions as an outer mitochondrial membrane protein involved in metabolite transport, apoptosis regulation, and mitochondrial dynamics [@zhang2019]. MTCH2 plays critical roles in neuronal survival and has been implicated in neurodegenerative diseases including Alzheimer's Disease and Parkinson's Disease.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Mitochondrial Carrier Homolog 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>MTCH2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitochondrial Carrier Homolog 2</td></tr>
<tr><td><strong>Chromosome</strong></td><td>11p15.4</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[123591](https://www.ncbi.nlm.nih.gov/gene/123591)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614215</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000135249</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y6C9](https://www.uniprot.org/uniprot/Q9Y6C9)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Metabolic Disorders, Cancer</td></tr>
</table>
</div>

Overview

MTCH2 is a phylogenetically conserved protein that localizes to the outer mitochondrial membrane. It belongs to the mitochondrial carrier family but exhibits unique structural and functional features that distinguish it from other family members. The protein plays multifaceted roles in mitochondrial biology, including metabolite transport, apoptosis regulation, mitophagy, and lipid metabolism [@liu2021].

In the nervous system, MTCH2 is essential for maintaining neuronal viability. It influences mitochondrial function in [neurons](/entities/neurons) through multiple mechanisms, and its dysregulation has been linked to neurodegenerative processes in both Alzheimer's Disease and Parkinson's Disease.

Function

Mitochondrial Membrane Transport

MTCH2 functions as a mitochondrial carrier with several key activities:

Outer Mitochondrial Membrane Protein

Unlike classic mitochondrial carriers that traverse the inner membrane, MTCH2 localizes to the outer mitochondrial membrane where it:

• Serves as insertase: Functions as a mitochondrial outer membrane insertase for proteins [@gonzalez2025]
• Regulates mitophagy: Controls mitophagy initiation and mitochondrial quality control [@yang2025]
• Interacts with Bcl-2 family: Associates with pro-apoptotic and anti-apoptotic proteins

Role in Apoptosis

MTCH2 is intimately involved in mitochondrial-mediated [apoptosis](/entities/apoptosis) pathways:

• MOMP regulation: Influences mitochondrial outer membrane permeabilization
• Cytochrome c release: Controls release of apoptotic factors
• tBid interaction: Facilitates BID translocation to mitochondria
• Cell death modulation: Alters sensitivity to apoptotic stimuli [@johnson2019]

Disease Associations

Alzheimer's Disease

MTCH2 is implicated in AD pathogenesis:

• Mitochondrial dysfunction: Altered MTCH2 contributes to mitochondrial dysfunction in AD neurons
• Amyloid-β impact: Aβ affects MTCH2 expression and function
• Energy deficit: Contributes to neuronal energy deficits
• Apoptosis sensitivity: May increase neuronal vulnerability to apoptotic cell death

Parkinson's Disease

In PD, MTCH2 plays several roles:

• Mitochondrial quality control: MTCH2-mediated mitophagy is critical for removing damaged mitochondria
• α-synuclein interaction: May affect α-synuclein toxicity
• Dopaminergic neuron survival: Essential for survival of [dopaminergic neurons](/cell-types/dopaminergic-neurons)
• Metabolic support: Provides metabolic support for high-energy demanding neurons

Metabolic Disorders

MTCH2 dysregulation contributes to:

• Obesity: MTCH2 variants affect lipid metabolism and adipocyte function
• Type 2 diabetes: Altered mitochondrial function in metabolic disease
• Cardiovascular disease: MTCH2 affects cardiovascular system function [@lee2023]

Cancer

MTCH2 expression is altered in various cancers:

• Metabolic reprogramming: Supports cancer cell metabolism
• Apoptosis resistance: May contribute to resistance to apoptotic stimuli
• Therapeutic target: Potential target for cancer therapy

Expression

Tissue Distribution

MTCH2 is ubiquitously expressed with high levels in:

• Liver: High metabolic activity
• Kidney: Transport functions
• Heart: High energy demand
• Brain: Particularly in neurons

Brain Expression

In the brain, MTCH2 shows:

• Neuronal expression: High expression in excitatory and inhibitory neurons
• Regional distribution: Present throughout the brain with highest levels in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
• Subcellular localization: Outer mitochondrial membrane

Regulation

MTCH2 expression is regulated by:

• Metabolic state: Altered by nutrient availability
• Cellular stress: Modulated by oxidative stress
• Developmental stage: Expression changes during brain development

Therapeutic Implications

Drug Development

MTCH2 is a potential therapeutic target:

• MTCH2 modulators: Small molecules targeting MTCH2 function
• Metabolic therapy: Modulating mitochondrial metabolism for neuroprotection
• Apoptosis modulation: Controlling apoptotic pathways in neurodegeneration

Biomarker Potential

MTCH2 may serve as:

• Disease biomarker: Altered expression in neurodegenerative disease brains
• Treatment response: Indicator of therapeutic efficacy
• Prognostic marker: Associated with disease progression

Research Directions

Key research areas include:

References

Cross-links

• [Mitochondrial Dysfunction in Neurodegeneration](/mechanisms/mitochondrial-dysfunction)
• [MTCH2 Protein](/proteins/mtch2-protein)
• [Apoptosis Pathways](/mechanisms/apoptosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease association
• [Parkinson's Disease](/diseases/parkinsons-disease) - Disease association
• [Mitophagy](/mechanisms/mitophagy) - Related pathway

See Also

• [Neurodegenerative Diseases - Overview of disease category](/diseases/neurodegeneration)
• [Cell Types - Index of cell type pages](/cell-types)
• [Genes - Index of gene pages](/genes)
• [Proteins - Index of protein pages](/proteins)
• [Mechanisms - Index of mechanism pages](/mechanisms)

Pathway Diagram

The following diagram shows the key molecular relationships involving MTCH2 — Mitochondrial Carrier Homolog 2 discovered through SciDEX knowledge graph analysis: